Papers

1

Total Citations

10

H-Index

1

About

Dr. Jan-Jaap J. Mellema is a leading urological oncologist whose work is reshaping the staging and surgical management of prostate cancer. His research centers on the integration of advanced molecular imaging—specifically prostate-specific membrane antigen (PSMA) PET/CT—into the pre-operative workup for high-risk patients. Dr. Mellema’s most cited study, published in 2024, provides pivotal evidence that PSMA PET/CT detects occult nodal and distant metastases far more effectively than conventional imaging. By demonstrating that this enhanced staging directly alters surgical planning—including the extent of pelvic lymph node dissection—his work has improved the accuracy of risk stratification and the oncological outcomes of radical prostatectomy. With over 10 citations in a short time, his findings are rapidly influencing clinical guidelines. Dr. Mellema’s contributions are vital for reducing unnecessary surgeries and optimizing personalized treatment pathways, marking him as a key figure in the transition toward precision surgery in urologic oncology.

Research Focus

Key Achievements

1
H-Index
1
Papers
10
Total Citations
10
Avg Citations/Paper
🏆 Most Cited Paper
Early Oncological Outcomes in Patients who Underwent Staging Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography Compared with Conventional Imaging Before Radical Prostatectomy and Extended Pelvic Lymph Node Dissection
10 citations · 2024
📈 Most Prolific Year: 2024 (1 Papers)
🤝 Key Collaborators: 12
🏛 Institutions: Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago